Finnrick - Ensuring a Safer and More Transparent Supply Chain
Uther

Uther
Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP antagonist) from Uther between 3 Jul 2025 and 18 Sep 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
Tentative Rating
Uther
Tirzepatide
Tested 4 Samples
Last test 18 Sep 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Uther

Samples are tested in commercial labs

Tests Count

4

Scores

AVG7.6MIN5.4MAX9.4

Last

18 Sep 2025

First

3 Jul 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
18 Sep 2025View8.045mg(no batch claim)45.200mg+0.4%99.92%(no batch ID)No Label / Green Crimp / Yellow Cap Lab EPublic
11 Aug 2025View9.430mg(no batch claim)28.100mg-6.3%99.83%Ze300623No Label / Black Crimp / Black Cap Lab EPublic
5 Aug 2025View7.610mg
11.8mg
10.100mg-14.2%99.85%ze100629White Label / Black Crimp / Blue Cap Lab EPublic
3 Jul 2025View5.410mg(no batch claim)11.000mg+10.0%99.47%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic